期刊文献+

西宁地区临床分离常见菌及耐药性分析 被引量:1

Analysis of common clinical isolates and drug resistance in Xining
原文传递
导出
摘要 目的:了解西宁地区临床分离出的病原菌的组成及耐药状况,为临床合理用药提供依据。方法:对2011年6月-2011年12月临床采集的标本常规培养分离后,应用英国先德ARIS全自动微生物鉴定仪进行细菌鉴定和药敏检测,再以Micro.soft Excel2007进行药敏结果统计。结果:本地区的临床分离菌以大肠埃希菌、金黄色葡萄球菌、肺炎克雷伯菌、铜绿假单胞菌、鲍曼不动杆菌、肠球菌为主,革兰阴性菌的敏感药物包括亚胺培南、阿米卡星、左氧氟沙星、头孢吡肟、头孢他啶,革兰阳性菌的敏感药物包括万古霉素、氯霉素、利福平、环丙沙星、四环素。结论:临床治疗感染应以本地区细菌种类和耐药监测结果为依据,合理应用抗生素。 Objective:To know the composition and drug resistance of pathogenic bacteria isolated from clinical patients in Xining regions for providing the evidence of rational drug use in clinic.Methods: The samples collected from clinical patients were cultured by routine method and pathogen bacteria were identified by automatic microorganism identification instrument produced by UK to Germany ARIS company from June to December in 2011.Furthermore,the susceptibility results were conducted statistics analysis with Micro.soft Excel2007.Results: The usual clinical isolates were Escherichia coli,Staphylococcus aureus,Klebsiella pneumoniae,Pseudomonas,Acinetobacter,Enterococci in local.The sensitive drugs of Gram-negative bacteria included imipenem,Amikacin,levofloxacin,cefepime,ceftazidime and those of Gram-positive bacteria included vancomycin,chloramphenicol,rifampin,ciprofloxacin,tetracycline.Conclusion: Treatment of infection should be based on local bacterial species and drug resistance monitoring results to guide the rational use of antibiotics.
出处 《中国卫生检验杂志》 北大核心 2012年第9期2146-2148,共3页 Chinese Journal of Health Laboratory Technology
关键词 病原菌 药敏试验 耐药性 Pathogenic bacteria Drug sensitivity test Drug resistance
  • 相关文献

参考文献7

二级参考文献24

  • 1黄晓琴.45株肺炎克雷伯菌下呼吸道感染的耐药分析[J].中华医院感染学杂志,2004,14(10):1171-1173. 被引量:31
  • 2杨青,俞云松,倪语星,孙景勇,徐英春,孙宏莉,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,卓超,苏丹虹,胡云建,艾效曼,黄文祥,贾蓓,张朝霞,季萍,张泓,李万华,魏莲花,吴玲,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET肠球菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):421-425. 被引量:61
  • 3李苏利,李杨,华川.多重耐药鲍氏不动杆菌耐药现状与临床对策[J].中华医院感染学杂志,2005,15(12):1438-1440. 被引量:102
  • 4Gbagurdi Haore h, Bertrand X, Muller A, et al. Are isolation meassures needed in the hospital management of Acientobacter baumannii colonrzations-infections[J]. Med Mal Infect,2006, 36(4) :201-206.
  • 5Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20, 2010.
  • 6Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 7Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20 Vol 30 No.1.
  • 8Clinical and Laboratory Standads Institute Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20-U Vol 30 No 15.
  • 9Clinical Laboratory Standard Institute.Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria[S].Approved Guideline M45-A,Vol.26 No.19,2006.
  • 10Wang P,Hu FP,Xiong ZZ,et al.Susceptibility of ESBL-Producing nterobacteriaceae with the New CLSI Breakpoints[J].J Clin Microbiol,2011,49(6):3127-3131.

共引文献689

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部